Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples